全球疫苗免疫联盟及其他发展援助渠道的捐助资金对疫苗接种覆盖率的影响:来自120个中低收入受援国的证据
研究利用1996至2016年受援国数据,采用标准时间序列横截面分析方法,估计全球疫苗免疫联盟(Gavi)疫苗与卫生系统强化支持及其他发展援助渠道免疫援助对百白破、肺炎球菌结合、五价、麻疹和轮状病毒疫苗覆盖率的影响。发现援助对较新疫苗有显著正向效应,并估算达到90%覆盖率所需人均额外援助及Gavi支持带来的接种儿童数。
要点
- 援助对较新疫苗覆盖率有显著正向效应
- 达到90%覆盖率所需人均额外援助因疫苗和国别而异
核心结论
- 分析表明全球免疫倡议的实施在历史和前瞻层面均取得实质性成功。
- 随着更多疫苗推广和各国从捐助援助过渡,需加强财政可持续性和效率策略以实现全民免疫覆盖。
研究设计与样本
- 利用1996至2016年受援国层面可得数据,采用标准时间序列横截面分析方法,控制国家收入、治理和人口,并进行不同模型设定的稳健性检验。
主要发现
- 发现援助对较新疫苗有显著正向效应。
- 以2016年国别支付和覆盖水平为基线,在低于全球目标的受援国中,达到90%覆盖率所需人均额外援助:PCV为0.01至4.33美元,五价疫苗为0.03至9.06美元,轮状病毒疫苗为0.01至2.57美元。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Donor assistance for immunization has remained resilient with increased resource mobilization efforts in recent years to achieve current global coverage targets. As a result, more countries continue to introduce new vaccines while optimizing coverage for traditional vaccines. Gavi the Vaccine Alliance has been at the forefront of immunization support specifically among low and middle income countries, alongside other channels of development assistance which continue to play a vital role in immunization. Using available recipient country level data from 1996 to 2016, we estimate the impact of Gavi support for vaccines and health systems strengthening on vaccine coverage for 3 dose DPT, 3 dose pneumococcal conjugate vaccine, 3 dose pentavalent, 2 dose measles and 2 dose rotavirus vaccines. We investigate the same effects of total aid for immunization from other channels of development assistance. Standard time series cross sectional analysis methods are applied to investigate the effects of vaccine support controlling for country income, governance and population, with robustness tests implemented using different model specifications. Double counting was eliminated and results are presented in real 2017 US dollars. We found significant positive effects of aid particularly among the newer vaccines. Using 2016 country specific disbursements and coverage levels as baseline, we estimated that among recipient countries below the universal target, additional DAH per capita required to reach 90%, ranged from 0.01USD to 4.33USD for PCV, 0.03USD to 9.06USD for pentavalent vaccine and 0.01USD to 2.57USD for rotavirus vaccine. The estimated number of children vaccinated through 2016, attributable to Gavi support totaled 46.6million, 75.2million and 12.3million for PCV, pentavalent and rotavirus vaccines respectively. Our analysis suggests substantial success both from a historical and prospective perspective in the implementation of global immunization initiatives thus far. As more vaccines are rolled out and countries transition from donor aid, strategies for fiscal sustainability and efficiency need to be strengthened in order to achieve universal immunization coverage.
引用
- Ikilezi G, Augusto OJ, Dieleman JL, et al. Effect of donor funding for immunization from Gavi and other development assistance channels on vaccine coverage: Evidence from 120 low and middle income recipient countries. Vaccine. 2019. PMID: 31679863. doi:10.1016/j.vaccine.2019.10.057
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。